Trade AbbVie ^ABBV

AbbVie Declares Quarterly Dividend PR Newswire NORTH CHICAGO

Cumberland Partners Ltd Acquires 19,130 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Raised by L & S Advisors Inc

NewEdge Wealth LLC Acquires 75,364 Shares of AbbVie Inc. $ABBV

Signet Financial Management LLC Cuts Stake in AbbVie Inc. $ABBV

Cornerstone Advisors LLC Sells 2,200 Shares of AbbVie Inc. $ABBV - Stock Observer

Ontario Teachers Pension Plan Board Buys Shares of 235,747 AbbVie Inc. $ABBV - Daily Political

AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - Stock Observer

Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited

Analysts Set AbbVie Inc. (NYSE:ABBV) PT at $251.00 - Daily Political

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases

Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks

AbbVie (NYSE:ABBV) Shares Down 1.7% - Here's What Happened

Dividend large caps Microsoft, AbbVie and PNC tied to AI

Calls of the Day: First Solar, Abbvie, Amgen, Ulta and Costco

AbbVie Inc. $ABBV Shares Acquired by Ingalls & Snyder LLC - Markets Daily

Waycross Partners LLC Purchases 8,077 Shares of AbbVie Inc. $ABBV

Ingalls & Snyder LLC Increases Stock Position in AbbVie Inc. $ABBV

Advisors Capital Management LLC Boosts Stock Holdings in AbbVie Inc. $ABBV - Daily Political

Facial Injectable Analysis Report 2025: An $18.89 Billion Market by 2029, Driven by New Product Launches, Emerging Markets, AI Innovations, Male Aesthetics, Younger Demographics

AbbVie Inc. $ABBV Shares Bought by NEOS Investment Management LLC

AbbVie Inc. $ABBV Shares Purchased by Colrain Capital LLC

Glenview Trust Co Has $95.89 Million Stake in AbbVie Inc. $ABBV

Arvest Bank Trust Division Cuts Stock Position in AbbVie Inc. $ABBV

A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia

Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

AbbVie Inc. $ABBV Position Boosted by Southeast Asset Advisors LLC

AbbVie Inc. $ABBV Shares Sold by M&G PLC | MarketBeat

AbbVie Inc. $ABBV Stake Cut by Zions Bancorporation National Association UT

Vanguard Group Inc. Acquires 448,554 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by Fifth Third Bancorp

Todd Asset Management LLC Lowers Stock Position in AbbVie Inc. $ABBV - Stock Observer

AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts

AbbVie Inc. $ABBV Shares Purchased by Capital Planning Advisors LLC - Stock Observer

AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - Daily Political

1 No-Brainer Dividend Stock to Buy on the Dip

Shell Asset Management Co. Trims Stake in AbbVie Inc. $ABBV - Markets Daily

Top Pharmaceutical Stocks To Watch Now - February 15th - Stock Observer

AbbVie (NYSE:ABBV) Shares Up 1.8% - Here's Why - Markets Daily

AbbVie Inc. $ABBV Stock Holdings Boosted by PNC Financial Services Group Inc. - Markets Daily

Investment Partners LTD. Sells 13,247 Shares of AbbVie Inc. $ABBV

HighTower Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV

GF Fund Management CO. LTD. Purchases 5,709 Shares of AbbVie Inc. $ABBV

Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off - AOL

WJ Financial Advisors LLC Makes New $557,000 Investment in AbbVie Inc. $ABBV - Markets Daily

Is It Too Late To Consider AbbVie (ABBV) After Its Strong Multi‑Year Share Price Run?

AbbVie Inc. $ABBV Shares Acquired by BTC Capital Management Inc. - Markets Daily

DDD Partners LLC Cuts Stock Position in AbbVie Inc. $ABBV

CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis

AbbVie (NYSE:ABBV) Trading 1.8% Higher - Time to Buy?

AbbVie (NYSE:ABBV) Stock Price Up 1.8% - Here's What Happened - Stock Observer

Glenmark's 25-Year Journey: From Challenges to $1.9 Billion AbbVie Deal, ETPharma

Where is AbbVie Inc. (ABBV) Headed According to the Street?

Metis Global Partners LLC Has $22.53 Million Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Public Sector Pension Investment Board

Aldeyra's Dry Eye Therapy Faces FDA In March - Will The Third Time Be A Charm?

Freemont Management S.A. Trims Stake in AbbVie Inc. $ABBV

Capital Investment Counsel LLC Sells 2,482 Shares of AbbVie Inc. $ABBV - Daily Political

Pharmaceutical Stocks To Watch Today - February 12th - Stock Observer

Savvy Advisors Inc. Raises Holdings in AbbVie Inc. $ABBV

AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform

Atria Investments Inc Decreases Stake in AbbVie Inc. $ABBV

Varma Mutual Pension Insurance Co Has $61 Million Stake in AbbVie Inc. $ABBV - Daily Political

Abbvie claims CMS' selection of Botox violates the IRA | BioWorld

Evercore ISI Cuts AbbVie Inc. (ABBV) PT, Says Consensus for 2026 and 2027 Still Looks Beatable

AbbVie Sues HHS Over Selection of Botox for Medicare Price Cuts

Abbvie sues US health agency over Botox

Dermal Fillers Market Forecast 2026-2036: Global Revenue to Reach USD 9.9 Billion by 2036 at 3.2%

ING Groep NV Purchases 528,196 Shares of AbbVie Inc. $ABBV - Markets Daily

Cibc World Market Inc. Acquires 60,635 Shares of AbbVie Inc. $ABBV

Rhumbline Advisers Decreases Stock Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie Reshapes U.S. Operations With Medicaid Concessions And Growth Focus

Top Pharmaceutical Stocks To Consider - February 10th - Markets Daily

AbbVie Inc. $ABBV Shares Sold by SVB Wealth LLC

Gilead Sciences News | Markets Insider

OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmology

Conducting Phase 3 Enabling Activities, Including Discussion

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 | Morningstar

How Recent Analyst Shifts Are Reframing AbbVie (ABBV) And Its Valuation Story

AbbVie, Astra Lose Appeal Over Louisiana Contract Pharmacy Law

ProShare Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV

Candriam S.C.A. Has $193.50 Million Holdings in AbbVie Inc. $ABBV

Oppenheimer & Co. Inc. Acquires 5,688 Shares of AbbVie Inc. $ABBV

3 Market-Beating Stocks to Research Further

Candriam S.C.A. Has $193.50 Million Position in AbbVie Inc. $ABBV - Daily Political

Prognostic impact of myelodysplasia-related gene mutations in FLT3 -ITD-mutated acute myeloid leukemia

AbbVie Inc. $ABBV Shares Sold by Alps Advisors Inc.

Smartleaf Asset Management LLC Raises Holdings in AbbVie Inc. $ABBV - Stock Observer

ABBV: Future Returns Will Depend On Immunology Pipeline Clarity And M&A Uncertainty

a16z Perennial Management L.P. Takes $581,000 Position in AbbVie Inc. $ABBV - Markets Daily